FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

INDOCO Share Price Discussion

Indoco Remedies Ltd.
Sector: Pharmaceuticals and health care
... Read more
INDOCO Long Term Analysts Rating
4.1/5 (9 Ratings)
INDOCO Share Price *
229 -0.8 (-0.35%)
* (quote may be delayed)

Find answers to all your questions on live INDOCO message board: Is INDOCO buy or sell? Should I buy INDOCO shares? Why are INDOCO shares falling? Should I invest in INDOCO stock?


You can also check INDOCO share price target recommended by brokerages.

INDOCO Discussion Forum

@RISHABHTYAGI • Reputation: 4,493
RJ ROCKET TRADES in INDOCO
*BUY INDOCO REMEDIES* *CMP 200* *TG 215/225/23...

*Watch our pick indoco remedies guys hit 245 from 200*
*20% up done*
*Enjoy the gains with rj team*
Like
reply
Reply
@ENRITCHansraj • Reputation: -40,247
INDOCO

Type
Buy
Instrument
INDOCO
Entry Price
₹224
Price@Trade
₹225.2
Target Price
₹240
Stop Price
₹215
Valid Till
Jan 20, 2020 3:20 PM
Margin
₹224 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-4.02% Loss
1
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Jan 20 2:48 PM

Update
Trade Entered
Entry Price
₹224
TrackerBot @trackerbot
Jan 20 4:00 PM

Update
Stoploss Hit
StopLoss
₹215
@ENRITCHansraj • Reputation: -40,247
INDOCO

Type
Buy
Instrument
INDOCO
Entry Price
₹231
Price@Trade
₹231.5
Target Price
₹240
Stop Price
₹225
Valid Till
Jan 20, 2020 3:20 PM
Margin
₹231 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-2.6% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Jan 20 2:46 PM

Update
Trade Entered
Entry Price
₹231
TrackerBot @trackerbot
Jan 20 2:46 PM

Update
Stoploss Hit
StopLoss
₹225
@RISHABHTYAGI • Reputation: 4,493
RJ ROCKET TRADES in INDOCO
*BUY INDOCO REMEDIES* *CMP 200* *TG 215/225/23...

indoco remedies blasted big up guys
209 from 200 till now
safer keep booking it here
pls
only positanal shud hold
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,493
RJ ROCKET TRADES in INDOCO
*BUY INDOCO REMEDIES* *CMP 200* *TG 215/225/23...

**jackpot buy indoco remedies guys we want upper circuit in it**
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,493

*BUY INDOCO REMEDIES*
*CMP 200*
*TG 215/225/230/240/250*
*SL 190*
*BUY FOR 10-20%% UPSIDE GUYS*
*ITS A BIG BUDGET BENIFICARY PICK*
Like
reply
Reply
@invictotrader • Reputation: 2,053

Indoco Remedies share price climbs 2% on USFDA nod Hyperuricemia can cause kidney disease and kidney stones as well.
Like
reply
Reply
@invictotrader • Reputation: 2,053

Indoco receives EU GMP from UK-MHRA for its Sterile facility in Goa (Plant II)
Like
reply
Reply
@databot • Reputation: 1,317

Karvy Stock Broking Recommendation on INDOCO
Date: 31-Oct-19 Broker: Karvy Stock Broking Price @ Call: 161.95 Target: 189 Recommendation: BUY
Like
reply
Reply
@databot • Reputation: 1,317

AnandRathi Recommendation on INDOCO
Date: 30-Oct-19 Broker: AnandRathi Price @ Call: 167.42 Target: 191 Recommendation: BUY
Like
reply
Reply
@databot • Reputation: 1,317

India Nivesh Recommendation on INDOCO
Date: 30-Oct-19 Broker: India Nivesh Price @ Call: 167.42 Target: 100 Recommendation: SELL
Like
reply
Reply
@umanath • Reputation: 563

INDOCO - 418488

Like
reply
Reply
@newsbot • Reputation: 1,933
Yes Bank, BHEL among 15 stocks that rose/fell the most in last week
The S&P BSE Mid-cap index gained 4.64 percent, S&P BSE Large-cap index rose 3.49 percent and the Small-cap Index was up 2.78 percent last week.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies gains 7% after zero observation from USFDA
The inspection was held from October 14 to 18.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies jumps 4% after USFDA concludes inspection of Goa Unit II
US FDA inspected Indico's Goa Unit II from October 7 to October 15. The stock gained over 8 percent in the last three days.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies gets USFDA nod for Parkinson's disease treatment drug
The company has received final nod for its abbreviated new drug application (ANDA) for Rasagiline tablets in the strengths of 0.5 mg and 1 mg from the United States Food and Drug Administration (USFDA), Indoco Remedies said in a regulatory filing.
Moneycontrol
1
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies gets 2 observations from UK health regulator for its Goa facility
The inspection by UK health regulator, MHRA were held from September 16-20, 2019 and resulted in 2 observations, Indoco Remedies said in a regulatory filing.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies rises 7% after successful closure of MHRA inspection
The inspection was held from 16-20 September, 2019 and resulted in 2 observations.
Moneycontrol
Like
reply
Reply
@umanath • Reputation: 563

INDOCO - 340541

Like
reply
Reply
Intraday Cash Trade in INDOCO
Sell-139 T-137 SL-141

Partial profit-137.50
Like
reply
Reply

Sell-139
T-137
SL-141
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies Consolidated June 2019 Net Sales at Rs 252.68 crore, up 0% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies up 7% on strong Q1, Hyderabad unit clears USFDA review
Revenue rose 16 per cent to Rs 252.7 crore from Rs 217.8 crore in Q1 2018
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Indoco Remedies surges 20% on USFDA report for Goa facility
The inspection was held from May 27, 2019 to June 04, 2019, where the company had received 4 observations (483s).
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
  • INDOCO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,867.88
    Enterprise Value2,073.7
    Price to Earnings47.37
    Price to Book Value2.83
    Return on Capital Employed0.08
    Return on Equity0.06
    Face Value2
    Dividend YieldNA
  • INDOCO Share Price - Technicals

    keyboard_arrow_down
    INDOCO - 52 Week High₹245
    INDOCO - 52 Week Low₹132.45
  • INDOCO - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    31-Oct-19Karvy Stock BrokingBuy189
    30-Oct-19AnandRathiBuy191
    30-Oct-19India NiveshSell100
    14-Aug-19Nirmal BangBuy290
    14-Aug-19Prabhudas LilladherReduce130
    INDOCO Brokerage Price Target
  • INDOCO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 22231233.5225.55227.5
    Jan 21212.3235.4210.1229.8
    Jan 20206.9245206.9212.3
    Jan 17200207198.7205.15
    Jan 16205.1207197.75199.5
  • INDOCO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹195.26
    30 Day Moving Average₹183.98
    50 Day Moving Average₹172.33
    100 Day Moving Average₹162
    200 Day Moving Average₹167.52
  • INDOCO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,0381,094.06-0.05
    Operating Profit135156.63-0.14
    Profit Before Tax4891.33-0.47
    Net Income4177.46-0.47
  • INDOCO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds661675-0.02
    Total Liabilities597601-0.01
    Total Assets1,2581,277-0.01
  • INDOCO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity12387.810.4
    Cash from Investing Activity-136-170.54-0.2
    Cash from Financing Activity-39132.4-1.29
    Net Cash Flow-5249.67-2.05
  • INDOCO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.06
    Return on Equity0.060.12
    Return on Capital Employed0.080.1
  • INDOCO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.22
    3 Year CAGR Growth in Operating Profit-0.18
    3 Year CAGR Growth in EBIDTA-0.16
    3 Year CAGR Growth in Net Income-0.5
    3 Yr CAGR Growth - Diluted EPS-0.51
  • INDOCO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.65
    5 Year CAGR Growth in Operating Profit0.46
    5 Year CAGR Growth in EBIDTA0.49
    5 Year CAGR Growth in Net Income-0.04
    3 Yr CAGR Growth - Diluted EPS-0.04
  • INDOCO - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 19 7:43 PM
    Yes Bank, BHEL among 15 stocks that rose/fell the most in last week
    Moneycontrol
    NewsBot
    Oct 18 9:13 PM
    Indoco Remedies gains 7% after zero observation from USFDA
    Moneycontrol
    NewsBot
    Oct 16 4:58 PM
    Indoco Remedies jumps 4% after USFDA concludes inspection of Goa Unit II
    Moneycontrol
    NewsBot
    Oct 7 4:33 PM
    Indoco Remedies gets USFDA nod for Parkinson's disease treatment drug
    Moneycontrol
    NewsBot
    Sep 23 5:43 PM
    Indoco Remedies gets 2 observations from UK health regulator for its Goa facility
    Moneycontrol
    NewsBot
    Sep 23 5:23 PM
    Indoco Remedies rises 7% after successful closure of MHRA inspection
    Moneycontrol
    NewsBot
    Aug 13 7:18 PM
    Indoco Remedies Consolidated June 2019 Net Sales at Rs 252.68 crore, up 0% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 13 6:43 PM
    Indoco Remedies up 7% on strong Q1, Hyderabad unit clears USFDA review
    moneycontrol.com
    NewsBot
    Jul 26 7:08 PM
    Indoco Remedies surges 20% on USFDA report for Goa facility
    moneycontrol.com
    NewsBot
    Jul 19 8:43 PM
  • INDOCO - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.